摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2-(4-(3-chloropropanoyl)phenyl)acetate | 107776-20-5

中文名称
——
中文别名
——
英文名称
ethyl 2-(4-(3-chloropropanoyl)phenyl)acetate
英文别名
[4-(3-chloro-propionyl)-phenyl]-acetic acid ethyl ester;[4-(3-Chlor-propionyl)-phenyl]-essigsaeure-aethylester;ethyl [4-(3-chloro-1-oxopropyl)phenyl]acetate;ethyl 2-[4-(3-chloropropanoyl)phenyl]acetate
ethyl 2-(4-(3-chloropropanoyl)phenyl)acetate化学式
CAS
107776-20-5
化学式
C13H15ClO3
mdl
——
分子量
254.713
InChiKey
FYZRMXFQFHKUHW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    73.5-74.5 °C
  • 沸点:
    380.0±32.0 °C(Predicted)
  • 密度:
    1.167±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    [EN] COMPOUNDS AND METHODS
    [FR] COMPOSÉS ET MÉTHODES
    摘要:
    本发明涉及新型视黄醛酸相关孤儿受体γ(RORγ)调节剂及其在治疗由RORγ介导的疾病中的应用。
    公开号:
    WO2013019682A1
  • 作为产物:
    描述:
    苯乙酸乙酯3-氯丙酰氯 在 aluminum (III) chloride 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以32%的产率得到ethyl 2-(4-(3-chloropropanoyl)phenyl)acetate
    参考文献:
    名称:
    [EN] COMPOUNDS AND METHODS
    [FR] COMPOSÉS ET MÉTHODES
    摘要:
    本发明涉及新型视黄醛酸相关孤儿受体γ(RORγ)调节剂及其在治疗由RORγ介导的疾病中的应用。
    公开号:
    WO2013019682A1
点击查看最新优质反应信息

文献信息

  • 5H,10H-imidazo\x9b1,2-a!indeno\x9b1,2-e!pyrazin-4-one derivatives, preparation
    申请人:Rhone-Poulenc Rorer S.A.
    公开号:US05902803A1
    公开(公告)日:1999-05-11
    Compounds of formula (I), wherein R is a hydrogen atom or a carboxy, alkoxycarbonyl, --CO--NR.sub.4 R.sub.5, --PO.sub.3 H.sub.2 or --CH.sub.2 OH radical, and R.sub.1 is an -alk-NH.sub.2, -alk-NH--CO--R.sub.3, -alk-COOR.sub.4, -alk-CO--NR.sub.5 R.sub.6 or --CO--NH--R.sub.7 radical. The compounds of formula (I) have valuable pharmacological properties and are antagonists of the .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor also known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive antagonists of the N-methyl-D-aspartame (NMDA) receptor and more specifically are ligands for NMDA receptor glycine modulator sites.
    式(I)化合物,其中R为氢原子或羧基、烷氧羰基、--CO--NR₄R₅、--PO₃H₂或--CH₂OH基团,R₁为-烷基-NH₂、-烷基-NH--CO--R₃、-烷基-COOR₄、-烷基-CO--NR₅R₆或--CO--NH--R₇基团。式(I)化合物具有宝贵的药理特性,是α-基-3-羟基-5-甲基-4-异噁唑丙酸(AMPA)受体即quisqualate受体的拮抗剂。此外,式(I)化合物是非竞争性N-甲基-D-天冬氨酸(NMDA)受体的拮抗剂,更具体地说是NMDA受体甘酸调节位点的配体
  • 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates
    申请人:Rhone-Poulenc Rorer S.A.
    公开号:US06057454A1
    公开(公告)日:2000-05-02
    A compound of formula (II): ##STR1## in which R is a hydrogen atom or a carboxy, alkoxycarbonyl, --CO--NR.sub.4 R.sub.5, --PO.sub.3 H.sub.2 or --CH.sub.2 OH radical, and R.sub.1 is an -alk-NH.sub.2, -alk-NH--CO--R.sub.3, -alk-COOR.sub.4, -alk-CO--NR.sub.5 R.sub.6 or --CO--NH--R.sub.7 radical. The compounds of formula (II) can be used to prepare compounds of formula (I): ##STR2## in which R and R.sub.1 have the same meanings as above. The compounds of formula (I) have valuable pharmacological properties and are antagonists of the .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, also known as the quisqualate receptor. The compounds of formula (I) are also non-competitive antagonists of the N-methyl-D-aspartate (NMDA) receptor and more specifically are ligands for NMDA receptor glycine modulator sites.
    式(II)的化合物:##STR1## 其中R是氢原子或羧基,烷氧羰基,--CO--NR.sub.4 R.sub.5,--PO.sub.3 H.sub.2或--CH.sub.2 OH基团,而R.sub.1是-烷基-NH.sub.2,-烷基-NH--CO--R.sub.3,-烷基-COOR.sub.4,-烷基-CO--NR.sub.5 R.sub.6或--CO--NH--R.sub.7基团。式(II)的化合物可用于制备式(I)的化合物:##STR2## 其中R和R.sub.1与上述含义相同。式(I)的化合物具有有价值的药理学特性,并且是α-基-3-羟基-5-甲基-4-异恶唑丙酸AMPA)受体的拮抗剂,也称为石菜酸受体。式(I)的化合物也是N-甲基-D-天门冬氨酸(NMDA)受体的非竞争性拮抗剂,更具体地说是NMDA受体甘酸调节剂位点的配体
  • COMPOUNDS AND METHODS
    申请人:Tempero Pharmaceuticals, Inc.
    公开号:US20140315881A1
    公开(公告)日:2014-10-23
    The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
    本发明涉及新型视黄酸相关孤儿受体γ(RORγ)调节剂及其在治疗由RORγ介导的疾病中的应用。
  • Polysoaps. II. The Preparation of Vinyl Soaps<sup>1</sup>
    作者:HAROLD H. FREEDMAN、J. PHILIP MASON、A. I. MEDALIA
    DOI:10.1021/jo01095a024
    日期:1958.1
  • Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid AMPA antagonists
    作者:Jeremy Pratt、Patrick Jimonet、Georg Andrees Bohme、Alain Boireau、Dominique Damour、Marc Williams Debono、Arielle Genevois-Borella、John C.R Randle、Yves Ribeill、Jean-Marie Stutzmann、Marc Vuilhorgne、Serge Mignani
    DOI:10.1016/s0960-894x(00)00561-8
    日期:2000.12
    The over-stimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been suggested to be associated with neurodegenerative disorders. Here we describe an original series of readily water soluble 4-oxo-imidazo[1,2-a] indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid derivatives. One of these compounds, 4f, exhibited nanomolar binding affinity, potent competitive antagonism at the ionotropic AMPA receptor and a long duration of anticonvulsant activity after administration by parenteral route in vivo. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多